Tackling the Challenge of Nitrosamines

New Nitrosamine Reference Materials

Setting the Standard for Quality

Recent recalls due to nitrosamines in some commonly prescribed drugs have manufacturers grappling with how best to mitigate the risk of these impurities above acceptable levels.

Given the heightened regulatory scrutiny over these impurities and their potential to directly impact patient health, there can’t be any second-guessing when it comes to the quality of the reference materials you choose to identify, characterize and control nitrosamines in your drug product.

Thus, leveraging our deep subject matter expertise on nitrosamines, synthetic chemistry and analytical development, USP has expanded its portfolio of nitrosamine reference materials to include:

  1. Over 60 well-characterized Pharmaceutical Analytical Impurities (PAI)* for simple nitrosamines and NDSRIs associated with drug substances like Sitagliptin, Duloxetine, and Rasagiline
  2. Eight USP Reference Standards to support methods in General Chapter <1469> Nitrosamine Impurities
EXAMPLES OF USP NITROSAMINE REFERENCE MATERIALS.
Item # Description Item # Description
1A04000 N-Nitroso Duloxetine Solution 1A08890 N-Nitroso Cinacalcet  | Coming Soon
- N-Nitroso Ritonavir | Coming Soon 1A04020 1-Methyl-4-Nitrosopiperazine Solution
1A04360 N-Nitroso Sitagliptin Amine 1A03960 N-Nitroso Sitagliptin Amine Solution 
1A04030 N-Nitroso Rasagiline Solution 1A05410 Deutero N-Nitrosodiethylamine Solution
1A05420 Deutero N-Nitrosodibutylamine Solution 1A04380 N-Nitroso Dabigatran Etexilate 
1A03930 N-Nitrosodipropylamine Solution 1A03940 N-Nitrosomethylphenidate Solution
1A04390 N-Nitroso Tamsulosin  1A03950 N-Nitrosopiperidine Solution
1A04200 N-Nitroso Metoprolol Solution 1A04240 N-Nitroso Labetalol Solution
1A04230 N-Nitroso Propranolol Solution 1A04220 N-Nitroso Atenolol Solution 
1A04250 N-Nitroso Bisoprolol Solution  1A03920 N-Nitroso Varenicline Solution
1175800 Deutero N-Nitrosodimethylamine (NDMA-d6)  1466607 N-Nitrosomethylphenylamine (NMPA)
1466641 N-Nitrosodibutylamine (NDBA) 1466674 N-Nitrosodimethylamine (NDMA)
1466652 N-Nitrosodiethylamine (NDEA) 1466685 N-Nitrosoethylisopropylamine (NEIPA)
1466663 N-Nitrosodiisopropylamine (NDIPA) 1466696 N-Nitrosomethylaminobutyric Acid (NMBA)
EXAMPLES OF USP NITROSAMINE REFERENCE MATERIALS.
Item # Description
1A04000 N-Nitroso Duloxetine Solution
1A08890 N-Nitroso Cinacincalet  | Coming Soon
- N-Nitroso Ritonavir | Coming Soon
1A04020 1-Methyl-4-Nitrosopiperazine Solution
1A04360 N-Nitroso Sitagliptin Amine
1A03960 N-Nitroso Sitagliptin Amine Solution 
1A04030 N-Nitroso Rasagiline Solution
1A05410 Deutero N-Nitrosodiethylamine Solution
1A05420 Deutero N-Nitrosodibutylamine Solution
1A04380 N-Nitroso Dabigatran Etexilate 
1A03930 N-Nitrosodipropylamine Solution
1A03940 N-Nitrosomethylphenidate Solution
1A04390 N-Nitroso Tamsulosin 
1A03950 N-Nitrosopiperidine Solution
1A04200 N-Nitroso Metoprolol Solution
1A04240 N-Nitroso Labetalol Solution
1A04230 N-Nitroso Propranolol Solution
1A04220 N-Nitroso Atenolol Solution 
1A04250 N-Nitroso Bisoprolol Solution 
1A03920 N-Nitroso Varenicline Solution
1175800 Deutero N-Nitrosodimethylamine (NDMA-d6) 
1466607 N-Nitrosomethylphenylamine (NMPA)
1466641 N-Nitrosodibutylamine (NDBA)
1466674 N-Nitrosodimethylamine (NDMA)
1466652 N-Nitrosodiethylamine (NDEA)
1466685 N-Nitrosoethylisopropylamine (NEIPA)
1466663 N-Nitrosodiisopropylamine (NDIPA)
1466696 N-Nitrosomethylaminobutyric Acid (NMBA)

 

USP Nitrosamines Exchange: A knowledge-based, online community for all-things nitrosamine.

Join USP's Nitrosamines Exchange for real-time conversations and insights from industry leaders. Learn about the latest strategies for reducing the risks related to nitrosamines.

Sign up to be notified when future USP Nitrosamine Reference Materials are released.

By providing your contact information to USP, and pressing the Sign up button, you consent to receive news and/or promotional alerts via email from USP. You may opt out at any time by following the instructions included in every email alert sent to you by USP. You further agree to terms of USP’s Privacy Policy.

Help shape the future of Pharmaceutical Analytical Impurities.
USP’s catalog of Pharmaceutical Analytical Impurities is growing rapidly. However, please tell us if you do not find a Nitrosamine required for your analytical work, by connecting with your USP Account Manager or emailing us at  PAI@usp.org.

*Pharmaceutical Analytical Impurities are released using a process developed by USP’s subject matter experts. The release process is based on internal policies, standard operating procedures, and requirements as defined by USP’s Quality Management System. USP is an ISO 9001:2015 certified facility. PAI products are different from official USP Reference Standards. PAI products are not required for compendial compliance.